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Multidrug resistance (MDR) is frequ–ently reported 
in clinical Gram-negative bacteria. This limits which 
therapeutic options are available and is a major cause 
of mortality when acquired as a nosocomial infection1,2. 
Moreover, no truly novel active antibacterial compound 
is currently in clinical trials. Thus, it is important to 
decipher the molecular basis of the MDR mecha-
nisms3–5. MDR is prevalent in key Gram-negative clini-
cal pathogens, such as Escherichia coli, Salmonella spp., 
Klebsiella spp., Enterobacter spp., Campylobacter spp., 
Acinetobacter spp. and Pseudomonas spp. Three major 
bacterial strategies have emerged for the development of 
drug resistance: the membrane barrier limits the intra-
cellular access of an antibiotic; the enzymatic barrier 
produces detoxifying enzymes that degrade or modify 
the antibiotic; and the target protection barrier impairs 
target recognition and thus antimicrobial activity6. These 
mechanisms can act simultaneously in clinical isolates, 
generating a high level of resistance. There are two dif-
ferent aspects to transport systems across the bacterial 
membrane — influx and efflux. Here, we focus on the 
influx of antibiotics, as the efflux has been extensively 
discussed in recent reviews5–8.
The outer membrane is the first line of defence for 
Gram-negative bacteria against toxic compounds9. This 
barrier comprises a lipid bilayer that is impermeable to 
large, charged molecules. Influx is largely controlled by 
porins, which are water-filled open channels that span 
the outer membrane and allow the passive penetration 
of hydrophilic molecules9–11. Different types of porins 
have been characterized in Gram-negative bacteria 
and classified according to their activity (non-specific 
or specific channel or selective pore), their functional 
structure (monomeric or trimeric) and their regulation 
and expression9–14.
E. coli produces three major trimeric porins — 
OmpF, OmpC and PhoE — and pioneering studies 
with these porins constitute the foundation of our cur-
rent knowledge of many other porins9,10. Thus, these 
outer membrane proteins (OMPs) (and their homo-
logues in other Gram-negative bacteria) are termed 
classical porins9. Despite their ‘non-specific’ nature, 
the members of this family can be classified according 
to a range of selective filters with respect to the charge 
and size of the solutes and charges in key regions of the 
porin channels: the OmpF and OmpC families show 
a slight preference for cations, whereas PhoE selects 
inorganic phosphate and anions9–12. Porins have been 
purified and reconstituted in various experimental sys-
tems (for example, liposomes and planar membranes) 
to analyse their physico-chemical parameters, such as 
conductance, selectivity and voltage gating10.
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Nosocomial
Hospital-acquired infection.
Conductance
A measure of translocated 
charges per unit time and 
voltage gradient.
Selectivity
The translocation efficiency 
of a channel for a particular 
type of ion with respect to 
another ion.
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Abstract | Gram-negative bacteria are responsible for a large proportion of antibiotic- 
resistant bacterial diseases. These bacteria have a complex cell envelope that comprises  
an outer membrane and an inner membrane that delimit the periplasm. The outer membrane 
contains various protein channels, called porins, which are involved in the influx of various 
compounds, including several classes of antibiotics. Bacterial adaptation to reduce influx 
through porins is an increasing problem worldwide that contributes, together with efflux 
systems, to the emergence and dissemination of antibiotic resistance. An exciting challenge 
is to decipher the genetic and molecular basis of membrane impermeability as a bacterial 
resistance mechanism. This Review outlines the bacterial response towards antibiotic stress 
on altered membrane permeability and discusses recent advances in molecular approaches 
that are improving our knowledge of the physico-chemical parameters that govern the 
translocation of antibiotics through porin channels.
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Voltage gating
Effect observed for some 
channels whereby a high 
voltage gradient causes a 
sudden closure of the ion 
current. The molecular origins 
remain unsolved.
β-lactam
A major family of antibiotic 
molecules.
Antibiotherapy
A therapy that uses antibiotics 
to treat infections.
Cephalosporins and 
carbapenems
Two subclasses of the β-lactam 
family.
General diffusion porins can be distinguished 
from the specific and ligand-gated porins by their 
poor substrate selectivity and their high probability of 
presenting an open conformation in the absence of any 
specific substrates9,10. Most porins that are involved in 
antibiotic transport belong to the classical OmpF or 
OmpC subfamilies. However, there are exceptions, 
such as OprD of Pseudomonas aeruginosa and porins 
from Acinetobacter baumannii and Neisseria spp. 
For more examples, consult the Transport Protein 
Database (see Further information). Many aspects of 
porin activity and physiology have previously been 
discussed in various reviews9–15.
β-lactams and fluoroquinolones are the prominent 
groups in our current antibacterial arsenal16 and their 
respective activities are strongly affected by the influx 
barrier in clinical isolates (TABLE 1). The porin channel 
is the entry pathway for both β-lactams and fluoroqui-
nolones, which block the synthesis of peptidoglycan 
and disrupt the activity of gyrase and topoisomerase, 
respectively, and induce a bactericidal cascade16,17. In 
this Review, we explore the recent clinical evidence for 
distinct bacterial strategies of porin modification to limit 
β-lactam uptake (FIG. 1): an exchange in the type of porin 
expressed; a change in the level of porin expression; and 
a mutation or modification that impairs the functional 
properties of a porin channel. a possible emerging 
mechanism, the synthesis of pore-blocking molecules, 
is also discussed (BOX 1). The clinical prevalence of 
these resistance strategies highlights the importance 
of deciphering the antibiotic influx process. Therefore, 
we also focus on recent state of the art techniques that 
allow the quantification of antibiotic transport and the 
understanding of molecular dialogue between the porin 
channel and the antibiotic.
Role of porins in antibiotic resistance
some Gram-negative bacteria, such as P. aeruginosa 
and A. baumannii, possess an innate low susceptibility 
to β-lactam molecules, a characteristic that is associated 
with reduced outer-membrane permeability9. In P. aerugi-
nosa, this reduced permeability is due to the low number 
of porins and their distinct physico-chemical properties 
compared with the porins of the Enterobacteriaceae9,18–20. 
In other Gram-negative species (such as Citrobacter, 
Enterobacter, Escherichia and Klebsiella), β-lactam sus-
ceptibility is closely related to the presence of non-specific 
porins that belong to the OmpC and OmpF groups9,15. 
several clinical studies have reported a modification of 
the porin profile in antibiotic-resistant isolates: resistant 
Enterobacteriaceae can exhibit a shift in the type of porin 
they express, a reduction in the porin expression level or 
the presence of a mutated porin (TABLE 1). These clinical 
strains, isolated during patient antibiotherapy, exhibit a 
characteristic decrease in cephalosporin and carbapenem 
susceptibility. an altered porin phenotype is also com-
monly associated with the expression of degradative 
enzymes, such as β-lactamases and cephalosporinases, 
which efficiently confer a high level of β-lactam resist-
ance14,21. It is important to consider the clinical evidence 
for the different strategies that are involved in reducing 
influx across the outer membrane. by exploring each 
mechanism in turn we illustrate a bacterial adaptive 
response to antibiotherapy that leads to MDR.
Alterations in porin expression
Porin exchange. a study of Klebsiella pneumoniae strains 
collected from different patients undergoing treatment 
indicated that the isolates exhibited modified outer-
membrane permeability22. In most of these isolates, 
OmpK35, which belongs to the OmpF porin group and 
has a large channel size, was replaced with OmpK36, 
which belongs to the OmpC porin group and possesses 
a smaller channel size. This observation suggests that a 
drastic modification of the porin balance occurs dur-
ing antibiotherapy. This is of particular interest owing 
to the differential β-lactam susceptibility reported in 
these K. pneumoniae porins. The level of susceptibility 
to β-lactams, including cefepime, cefotetan, cefotaxime 
and cefpirome, in strains expressing OmpK35 is 4–8 
times higher than that conferred by OmpK36 (rEF. 23). 
The clinical isolates collected after antibiotic treatment 
exhibited an altered porin phenotype, with a simultane-
ous overexpression of an acrab efflux pump for extru-
sion of incoming antibiotic molecules. Together, these 
modifications severely decrease the intracellular drug 
concentration22.
several studies have observed that there is a rela-
tionship between the balance of porin expression 
and β-lactam susceptibility in clinical K. pneumoniae 
isolates24–30. a similar phenomenon has been reported 
in a patient infected with Salmonella enterica subsp. 
enterica serovar Typhimurium. all isolates collected 
Table 1 | Porin modification in Gram-negative bacteria
bacteria characterized 
porins
3D structure 
of porins
Porin alteration 
in clinical isolates
Enterobacter cloacae, 
Enterobacter aerogenes
Omp36*, Omp35‡ None Omp36§, Omp35§, 
Omp 36||
Escherichia coli OmpC*, OmpF*, 
OmpN¶, PhoE
OmpC31, 
OmpF30, PhoE30
OmpC§, OmpF§, 
OmpC||
Klebsiella pneumoniae OmpK36*, 
OmpK35‡, OmpK37¶
OmpK3632 OmpK35§, 
OmpK36§
Morganella morganii Major porin 
(36 kDa)
None Major porin
Neisseria gonorrhoeae Major porin None Major porin (PorA§||, 
PorB§||)
Pseudomonas 
aeruginosa
Porins, OprD OprD33 Porins§, OprD§, 
OprD||
Salmonella enterica 
subsp. enterica 
serovars Typhimurium 
and Enteritidis 
OmpC*, OmpF‡, 
OmpD
None Major porins 
(OmpC§, OmpF§, 
OmpD§)
Serratia marcescens Omp1*, Omp2‡ None Major porins 
(Omp1§, Omp2§)
Shigella dysenteriae None None Major porins 
(OmpC§, OmpF§)
*OmpC family. ‡OmpF family. §Identification of porin loss in resistant isolate. ||Identification of 
porin mutation in resistant isolate. ¶Quiescent porin family.
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before the start of antibiotherapy were susceptible to 
cephalosporins (cephalexin, cefazolin and cefoxitin)31. 
However, only days after the start of cephalexin treat-
ment, a cephalosporin-resistant strain was isolated from 
a wound drain sample. This direct clonal descendent of 
the original pre-therapy strain exhibited complete resist-
ance to all cephalosporins. no significant increase in 
β-lactamase activity was observed. The OmpC–OmpF 
balance is strongly regulated by different genetic control 
systems, such as EnvZ–OmpR and Rna anti-sense regu-
lators (MicF and MicC)6,9–10,12,13. In vitro, osmoregulation 
of porin synthesis in the susceptible parental strain was 
normal: only OmpC-type porins were expressed in high 
osmolarity medium and both OmpC- and OmpF-type 
porins were detected in low osmolarity medium. by 
contrast, the resistant isolate expressed only OmpF-type 
porins in low ionic strength conditions, and the synthe-
sis of OmpC- and OmpF-type porins was fully repressed 
at high osmolarity, mimicking the conditions that are 
present in vivo31.
These observations pinpoint a key step in bacterial 
adaptation: expression of the OmpC porin with its 
restrictive channel is generally favoured in vivo, mainly 
owing to conditions of high osmolarity in patients. This 
regulation naturally limits the entry of large, charged 
molecules. The different diffusion rates of cepha-
losporins through OmpC and OmpF has been shown 
using liposome swelling assays32. Continued exposure 
to sub-inhibitory antibiotherapy selects for step by step 
porin-expression modifications, resulting in further 
reduced influx at each stage14. Complete impermeability 
to β-lactams is achieved through total loss of the OmpC 
porin in resistant isolates and can represent an ‘extreme 
step’ in the porin adaptive response. This sacrifice can 
result in severe loss of bacterial fitness owing to restricted 
entry of nutrients, but can enable survival in the face 
of intensive and continuous antibiotherapy6,33. a rapid 
change in the balance of porin expression in response 
to antibiotic treatment confers a noticeable advantage to 
the pathogen compared with the commensal microflora 
that is susceptible to β-lactams.
a possible option for Enterobacteriaceae to maintain 
fitness following the loss of OmpC involves a further 
possible porin exchange to exploit a quiescent porin34. 
This novel porin subfamily (structurally related to 
the OmpC and OmpF subfamilies), termed Ompn-
type porins, comprises E. coli Ompn, K. pneumoniae 
OmpK37 and Salmonella enterica subsp. enterica serovar 
Typhi (s. typhi) Omps2. It has been demonstrated that 
when OmpK37 is expressed in a porin-null K. pneumo-
niae strain, a strong decrease in β-lactam susceptibility 
 Box 1 | Effects of porin blockers
Polyamines are polycationic molecules that modulate the activity of various ion channels83. Among these, spermidine, 
cadaverine and putrescine are produced by bacteria83. So far, few data are available concerning the in vitro effects of 
polyamines on the diffusion of antibiotics through the porins of Escherichia coli and Enterobacter cloacae. Spermine has 
been reported to inhibit OmpF channel properties83–86, to protect E. coli from colicin action and to decrease the diffusion 
of norfloxacin and cefepime through OmpF87. In addition, cadaverine has been shown to reduce ampicillin and 
cephaloridine susceptibility in E. coli by promoting an inhibition of ionic flux through cationic porins85,88. Thus, inhibition 
of porin transport by excreted cadaverine might represent a mechanism that provides bacterial cells with the ability to 
survive acid stress and nitrosative stress89–91. In the presence of antibiotics that use porins to cross the membrane barrier, 
cadaverine might play the part of pore modulator and reduce the penetration rate of these antibacterial agents. The 
conditions found in the intestinal tract favour the synthesis of polyamines and can be exploited by the enterobacterial 
pathogens that colonize this site. This adaptive response might function to block the transport of toxic compounds, such 
as bile acids and β‑lactam antibiotics.
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Figure 1 | multidrug resistance mechanisms associated with porin modification. 
Shows the various resistance mechanisms that are associated with porin modification. 
The β-lactam molecules and porin trimers are represented by blue circles and pink 
cylinders, respectively. The thickness of the straight arrows reflects the level of 
β-lactam penetration through porin channels. The curved arrows illustrate the uptake 
failure that occurs with: a change (decrease) in the level of porin expression; an 
exchange in the type of porin that is expressed (restricted-channel porin); and 
mutation or modification that impairs the functional properties of a porin channel 
(mutated porin). The effect of pore-blocking molecules (black circles) is shown at the 
bottom of the figure.
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Bacteraemia
A medical condition in which 
bacteria enter the bloodstream.
is observed compared with the susceptibility that is 
observed when OmpK35 or OmpK36 is synthesized 
at the same level35. This has so far only been illustrated 
in vitro and, although the conditions required for native 
expression of these quiescent porins are not yet known, 
it seems that the structural organization of the internal 
loop 3 of Ompn can constitute a selective filter for 
charged molecules. Expression of these porins would 
allow normal nutrient acquisition, but the presence of 
a bulky tyrosine residue, located inside the pore eyelet, 
could restrict the channel size and impair the penetration 
of large β-lactams, such as cefotaxime or cefoxitime35.
Decreased porin expression. a study reported the effect 
of imipenem on Enterobacter aerogenes strains collected 
from four patients during the course of imipenem ther-
apy36 (2–9 weeks). The emergence of resistant variants 
occurred rapidly, within 5 days of the start of treatment. 
Molecular epidemiological analysis indicated that the 
resistant variants evolved from an original susceptible 
E. aerogenes strain that belonged to the prevalent clone37. 
In addition, restoration of imipenem susceptibility was 
observed in isolates that were recovered a few days after the 
treatment ended. This suggests that an efficient regulation 
mechanism is involved in porin expression36. an asso-
ciation was reported between the presence of the major 
Omp36 porin (OmpC homologue) and the β-lactam sus-
ceptibility of the various isolates that were collected during 
this study. The absence of Omp36 always correlated with 
β-lactam (cephalosporin and imipenem) resistance and 
imipenem susceptibility36. These data clearly show that 
in vivo antibiotic treatment can select for the emergence 
of a resistant phenotype that is associated with porin loss 
from an original susceptible isolate. The simultaneous 
detection of an efflux pump in these resistant isolates 
suggests that a complex process regulates both influx 
and efflux36,38. In addition, up to 6% of highly β-lactam-
resistant E. aerogenes isolates collected over a 1-year 
period lacked porins, indicating the importance of porin 
regulation that is associated with β-lactamase production 
in the emergence of β-lactam-resistant strains39.
Thiolas et al.40 found a correlation between a suc-
cessive antibiotherapy, imipenem followed by colistin, 
and the isolation of E. aerogenes strains with sequential 
adaptive modifications. a decrease in porin produc-
tion was detected in the resistant isolates that were 
collected during imipenem therapy, and a lipopolysac-
charide alteration associated with porin recovery was 
reported in the isolates that were obtained during col-
istin therapy40. a similar scenario was reported in the 
case of a patient who presented with bacteraemia due 
to Enterobacter cloacae and was treated with imipenem 
and amikacin over 3 weeks41. Two weeks after the ces-
sation of antibiotherapy, a resistant strain was isolated. 
Characterization of the susceptible and resistant isolates 
indicated that transcription of the major E. cloacae 
porins was severely decreased and that the expression 
of an inhibitor-sensitive efflux system was increased in 
the resistant isolate41. This observation suggests that a 
genetic regulation cascade through the Mar operon is 
involved in porin expression. This regulon, which was 
described in Enterobacteriaceae, comprises a repressor 
(marR) that binds to an operator (marO) upstream of an 
activator5–7 (marA). De-repression of marA in response 
to several chemical and antibiotic stresses triggers a cas-
cade of events that results in global control of membrane 
permeability by the downregulation of porin synthesis 
and overexpression of efflux pump components5–8,15,42. 
In K. pneumoniae, several isolates have an insertion 
sequence (such as Is5 and Is26) in the OmpK36 and 
OmpK35 genes43–45. This insertion, which abolishes 
porin expression, effects an efficient bacterial response 
to β-lactam stress.
Mutations in porins. X-ray crystallography has resolved 
the intricate structural details of several porins (reviewed 
in rEFs 10,11). The internal loop 3 forms a constriction 
at about half the height of the β-barrel. This ‘eyelet’ gov-
erns channel size and ion selectivity10,11. In the eyelet, 
several positively charged amino-acid residues (the 
arginine cluster) on one side of the lumen face negatively 
charged residues on the opposite side, creating a strong 
electrostatic field that influences translocation through 
the porin (BOX 2). The conserved internal loop 3 (rEF. 46) 
therefore constitutes a crucial region of the enterobac-
terial porin channel and has a major influence on the 
influx of antibiotics. Genetic mutations in this loop 
can alter the levels of susceptibility to antibiotics that 
translocate porin channels. In this section, we focus 
on naturally occurring porin mutations that have been 
detected in clinical isolates.
low et al.47 performed a molecular study of several 
E. coli strains that were collected during long-term anti-
biotherapy. Over a period of 2 years, a complex treat-
ment regimen, comprising the successive use of several 
antibiotic classes (including fluoroquinolones, cepha-
losporins and carbapenems), was used. seven isolates 
from blood samples or liver abscesses were collected at 
different stages of the treatment. These isolates exhibited 
progressively increased levels of antibiotic resistance, and 
all harboured the same two mutations (D18E and s274F) 
in the OmpC porin, which might influence antibiotic 
 Box 2 | Porin structure and activity
The crystal structures of porins from Rhodobacter capsulatus and Escherichia coli 
indicate the existence of a conserved 16‑strand anti‑parallel β‑barrel structure for each 
monomer that contains a long internal loop, which is bent inside the pore11. OmpF of 
E. coli is the best studied porin, both functionally and structurally. Its crystal structure66 
enabled better understanding of channel function properties, such as solute‑exclusion 
limit and biological activity9–11. Using the three‑dimensional (3D) structure, several 
OmpF mutants have been constructed to examine the role of specific residues during 
assembly and function. In the pore constriction area (eyelet region), various 
mutagenesis and electrophysiological studies have focused on the positive cluster 
(Lys16, Arg42, Arg82 and Arg132) and the negative face (Asp113, Glu117 and Asp121), 
which are important for the electrostatic field that governs the diffusion of charged 
molecules9,10. The recent 3D structure of OmpC67, the major porin that is detected in 
clinical Gram‑negative bacteria, indicates that the general organization of the channel 
is well conserved between OmpF and OmpC, except that the respective pore lining is 
altered at the extracellular entrance66,67 (located just before the constriction region). 
The comparison between OmpF, OmpC activity and the solved structure of the major 
Klebsiella pneumoniae porin92, OmpK36, defines the two groups of major enterobacterial  
porins, OmpC‑ and OmpF‑class porins (TABLE 1).
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influx. Two final and most resistant isolates, which were 
obtained after carbapenem (meropenem and imipenem) 
treatment, showed a severe reduction in OmpC synthe-
sis compared with the first five isolates47. In addition, 
the few OmpC porins that were produced by these two 
isolates harboured an additional R124H substitution in 
the region that lines the pore, which causes an altera-
tion in the arg cluster positioned in the pore eyelet67. 
Comparison of the nucleotide sequences of ompC in 
the 7 isolates indicated that a common sequence modi-
fication (100 base changes compared with E. coli K-12 
ompC) was preserved. Epidemiological typing of these 
isolates supports the idea that they evolved from a single 
original infecting strain47.
a key porin mutation has also been detected in 
E. aerogenes clinical isolates that have high-level β-lactam 
resistance48. Molecular and functional analyses charac-
terized this G112D substitution, which is located inside 
internal loop 3 (rEF. 49). This substitution is similar to the 
G119D mutation, previously obtained by mutagenesis of 
E. coli ompF, which creates a major protrusion into the 
channel lumen, causing strong steric hindrance in the 
channel and a drastic reduction in β-lactam susceptibil-
ity50,51. The Omp36 G112D mutation severely impairs 
β-lactam diffusion through the channel, and the kinetics 
of cefepime uptake are greatly reduced in E. aerogenes 
isolates that carry this mutation52,53. Electrophysiological 
changes in the G112D porin channel, compared with 
wild-type E. aerogenes Omp36, are similar to those 
observed with the E. coli OmpF G119D mutation49,50.
Currently, the OmpC and Omp36 porin mutations 
that were detected in clinical strains isolated after 
antibiotic treatment are the only examples of direct 
in vivo selection of a functional porin mutation in the 
Enterobacteriaceae. nevertheless, the few molecular 
studies that have been carried out on clinical strains 
suggest that the frequency of such mutations might 
be underestimated. In addition, with the increasing 
use of antibiotics, such as carbapenems, that are spe-
cifically designed to resist degradation by the bacterial 
enzymatic barrier, the pathogen must adopt a novel 
response to restrict intracellular antibiotic concentra-
tion. Consequently, this type of mutation, located inside 
the constriction area of the channel, is likely to become 
more common in the future.
several Neisseria gonorrhoeae porin mutations have 
been linked to penicillin and tetracycline resistance. 
sequence analyses of the por gene have identified amino-
acid substitutions (G120D, a121D and G121K) in the 
putative internal loop 3 in various resistant strains54,55. 
Other mutations at these positions have been identified 
in resistant clinical isolates from a separate study, empha-
sizing the importance of these residues in the penicillin-
resistant phenotype54,56. substitution of these amino-acid 
residues using targeted mutagenesis has clearly shown 
that they have a role in antibiotic diffusion55,57.
both clinical and in vitro studies have reported that 
aberrant or modified P. aeruginosa OprD porin is linked 
to carbapenem resistance, with or without the produc-
tion of a carbapenem hydrolyzing enzyme58,59. In addi-
tion, several mutations that confer reduced carbapenem 
susceptibility have been reported in the oprD gene60. 
The OprD crystal structure has recently been solved61. 
several OprD residues belonging to loops 3 and 7 and 
a number of backbone residues create an asymmetric 
charge distribution and participate in the formation of 
the pore-constriction zone. some mutated residues have 
previously been reported in carbapenem-resistant iso-
lates and are located in or near loops 6 and 7 (rEFs 60,61). 
as the constriction zone constitutes the region of the 
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a  Impermeable — no influx b  Permeable — water influx c  Liposome bursting  — polymer release
AntibioticsSugars Porins
Figure 2 | liposome swelling assay. a | Multilamellar liposomes are prepared in the presence of a polymer (indicated by 
a yellow circle)63–65. A small aliquot of liposomes is rapidly mixed in a polymer-free solution that con ains the molecule of 
interest and that has the same osmotic pressure. If the molecule (for example, an antibiotic) cannot permeate, the optical 
density remains unchanged. b | If the molecule can permeate, the permeation will create an osmotic gradient and water 
will swell the liposome. c | Eventually, the liposome will burst and release the polymer. This will lead to a decrease in optical 
density. The decrease in optical density allows researchers to draw conclusions about the permeation rate.
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Permeation
Diffusion through a membrane, 
either through the lipid or 
through channels or carriers.
porin channel that has the greatest influence on the dif-
fusion of antibiotics, it is easy to understand how muta-
tions in loop 7 affect antibiotic susceptibility. Further 
analysis is required to understand why mutations in 
other regions might have this effect. Interestingly, the 
main cellular function of OprD is the passive uptake 
of basic amino acids as well as of small peptides20. In 
addition, overproduction of efflux pumps and other 
resistance mechanisms, together with the decrease of 
OprD expression, are involved in high-level imipenem 
and carbapenem resistance62.
The clinical data discussed here highlight the 
correlation between antibiotic susceptibility and 
outer-membrane permeability. The level of antibiotic 
diffusion through channels depends on their quantity 
and structure. It has become clear that the transport 
of β-lactams or fluoroquinolones occurs by passive 
diffusion through porins, but also involves specific 
interactions with the porin channel. The pathway of 
the antibiotic molecule through the channel is of cru-
cial importance for the intracellular accumulation of 
antibacterial drugs. Electrophysiological approaches 
are now being applied to decipher the interactions 
between the antibiotic and exposed residues inside 
the channel and aid the design of new antibiotic 
molecules with improved penetration capacities to 
circumvent the permeability barrier that resistant 
isolates have developed.
Physico-chemical basis of porin transport
The outer membrane is the first barrier against the 
environment, and bacteria can modulate its perme-
ability by modifying the number of channels and 
surface properties. To understand how to overcome 
the bacterial adaptive response to antibiotics, physical 
tools have been developed to delineate the transport 
pathways of antibiotics through porins, providing 
parameters that could be used to develop new antibiot-
ics. surprisingly few physico-chemical measurements 
have been performed to characterize the permeation 
of substrates across membrane channels. so far, porin 
permeation has been characterized qualitatively using 
liposome-swelling assays63–65 (FIG. 2). Only recently has 
it become possible to obtain quantitative electrophysi-
ological measurements using reconstituted artificial 
membranes10. In this way, several antibiotics have 
been screened for diffusion properties, and putative 
pathways either across the lipid membrane or through 
a particular channel have been deduced (BOX 3).
High-resolution structures are now available for 
some bacterial porins, including OmpF and, more 
recently, OmpC66,67. Inspection of the porin structure 
suggests that the permeation of molecules through 
the channel is driven by molecular interactions with 
the surface rather than by free diffusion68,69. The first 
evidence for facilitated diffusion through a binding site 
was found in maltoporin, a maltose-specific channel 
from the outer membrane in E. coli70–73. a closer look at 
the OmpF structure revealed that it possesses a possible 
affinity site for ampicillin molecules (FIG. 3). The acidic 
groups of ampicillin have been predicted to interact 
with a cluster of three arg residues (the arg cluster) in 
the OmpF constriction zone, as mentioned above. The 
ammonium group on the opposite side of the molecule 
has been suggested to interact with glutamate. In addi-
tion, the phenyl group is attracted to a hydrophobic 
pocket66,68. This observation has led to the develop-
ment of molecular modelling approaches to elucidate 
the possible pathways of antibiotics through the OmpF 
channel69,74,75. Here, we describe the biophysical meth-
ods that can be used to estimate translocation rates 
through porins.
Molecular mechanisms of diffusion through porins. 
To explore the influence of antibiotic–porin interactions 
on the diffusion rate (permeation), the flux through a 
channel in the absence of any interaction can be esti-
mated. For this purpose, the porin is considered to be a 
perfect cylinder with no interactive sites. The influx J (sub-
strate molecules per second) through a non-interacting 
cylinder is calculated using Equation 1.
Nature Reviews | Microbiology
J = –DNA (πa2/l) • ∆c (1)
In Equation 1, D is the diffusion constant of the 
particle, na = 6.023 x 1023 per mole, the avogadro 
constant, and the bracket contains the geometrical 
factor for a cylinder with ‘a’ as the pore radius and ‘l ’ 
as the approximate channel length. The driving force 
for the flux is the concentration gradient ∆c. Inserting 
approximate values of D = 10–9 m2 per s, a = 0.5 nm, 
l = 4 nm and ∆c = 1 mM gives a flux of about 105 mol-
ecules per s and corresponds to the fastest possible 
permeation (diffusion limit). However, the antibiotic 
molecules have about the same dimensions as the chan-
nel, reducing the effective pore size and thus the flux 
to nearly zero.
To understand permeation on a molecular level, 
one must account for the molecular interactions (dia-
logue) that take place between the channel and the 
translocating molecule. This dialogue provides 
the molecular specificity and it is chemical structure, 
which exert the dominant influence on permeation 
pathways (and not the molecules size). The current 
understanding of the molecular mechanism of antibiotic 
permeation is based on the available high-resolution 
crystal structure of OmpF66,68,69. This structural knowl-
edge, together with an extensive collection of relevant 
mutants, now offers a unique opportunity to model 
and modify the surface of the OmpF channel and to 
compare the theoretical transport pathways with flux 
experiments.
Fluctuations in the ion current that pass through 
porins that have been reconstituted into artificial mem-
branes occur when the antibiotics penetrate into the 
channel and report the occupancy of a ‘binding pocket’ 
inside the channel. an analysis of the equilibrium 
fluctuation allows the calculation of chemical rates for 
association and disassociation with the binding pocket 
(or interaction site) inside the channel. Determination 
of the on and off rates allows the net permeation rate to 
be obtained. Pioneering studies on maltose permeation 
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 Box 3 | Electrophysiology studies
The experimental method of choice for characterizing channel‑forming proteins is to measure conductance through 
purified porins that are re‑constituted into artificial membranes. For example, in the figure, part a, two symmetrical 
compartments (cuvettes) of a Teflon chamber, separated by a thin Teflon film that contains a round aperture of 60–80 µm 
in diameter are shown. Across this aperture a lipid membrane is formed. Single‑channel porin insertion is achieved by 
adding a porin stock solution. Injection into the cuvette corresponds to a dilution of the detergent micelles and some 
porins will insert into the membrane. Choosing the appropriate concentration allows single protein insertion, and 
multiple insertions can be avoided by flushing the cuvette with fresh buffer. Application of a transmembrane electric field 
allows the characterization of the electrical properties of the membrane and later of the reconstituted channel. Insertion 
of a channel gives rise to a measurable jump in current68. Currently, this technique can be miniaturized and automated93.
An external voltage is applied to the system and will cause an ion flux through inserted porin channels (see the figure, 
part b. The strength of the ion flux under different conditions (salt, concentration, pH and external voltage) will reflect 
the channel’s structure and functional properties, such as ion selectivity (for example, the ratio of potassium to 
chloride permeability). Conductance measurements suggest that OmpF and OmpC have a pore size of almost 1 nm, 
and this was confirmed by high‑resolution structure analyses66,67.
Addition of antibiotics or sugar molecules on one (or both) side of the bilayer causes them to diffuse towards the 
channel. High‑resolution ion‑current fluctuation analysis allows detection of the passage of single molecules and thus 
characterization of facilitated permeation of sugars and antibiotics68–70. Addition of millimolar concentrations of 
ampicillin to the system can cause fluctuations in the ion current. A typical recording is shown in the figure, parts c–e. 
The permeation of ampicillin into the channel causes a short interruption (~1 ms) of the ion conductance through 
OmpF. These fluctuations reflect interactions between the antibiotic molecules and the channel and can be resolved 
on a single‑molecule level. They correspond to the occlusion of one monomer channel of the trimeric porin during a 
fraction of a millisecond. Increasing the ampicillin concentration causes a corresponding increase in the number of 
fluctuations observed, whereas the average time of channel blockage by antibiotic molecules is independent of the 
antibiotic concentration. Analysing the frequency of such fluctuations allows us to obtain the kinetic rates for 
interaction with the affinity site in the channel68,70.
In the figure, part a shows the artificial membrane apparatus that is used to analyse the channel properties of porins, 
part b shows an expanded view of a single pore within the artificial membrane, part c shows increased conductance 
following addition of a channel to the artificial membrane and part d shows conductance through a channel. The average 
current is 200 pA (1 M KCl; transmembrane potential of 50 mV). Antibiotic molecules (5 mM ampicillin) permeate inside 
the channel and block the entrance of ions. Part e shows one blocking event (about 1 ms), and the amplitude corresponds 
to one‑third of the trimeric conductance. A statistical analysis reveals the on and off rate of the permeation. Figure 
courtesy of T. Mach, Jacobs University, Bremen, Germany. 
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Loop 3
Asp113
Asp132 Glu117
Arg82 Arg42
through maltoporin (lamb) led to the development 
of an asymmetric single-binding-site model70–73. The 
translocation is described by Equation 2.
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(extracellular) (channel)
A + P
(periplasm)
P + A′′AP (2)
k′on k′′o
k′o k′′on
The symbols P and aP indicate a channel state that is 
unoccupied or occupied by a bound antibiotic molecule, 
respectively; a and a′′ indicate free extracellular and 
periplasmic substrate, respectively.
It is interesting to note that in the case of maltoporin, 
an asymmetry in translocation was observed71. However, 
for simplicity, we only describe the symmetric model 
only. Following the previous derivation we can calculate 
the flux70,74 with Equation 3.
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J = [kon/(2 + K ∆c] • ∆c (3)
K is the apparent binding constant when an antibiotic 
is added to one side of the membrane and kon is the asso-
ciation rate for the substrate with the binding site. at low 
antibiotic concentrations (non-saturating conditions), 
the net flux is proportional to concentration gradient ∆c 
and to the association rate. It should be noted that for 
strong binding, permeation is limited by the dissociation 
rate and for a high concentration gradient (∆c) the flux is 
independent of the concentration gradient. More sophis-
ticated models have been suggested, and these allow the 
inclusion of detailed binding parameters76–78. However, 
with the limited accuracy of the measurements and the 
poor knowledge of molecular parameters, this simplified 
model might satisfy most of the current needs. Inserting 
experimental values — for example, for ampicillin perme-
ating through OmpF kon ≈ 104 [Ms]–1 (moles per litre per 
second) and K ≈ 1 [Ms]–1 — provides about 10 molecules 
per second per monomer under a 1 mM concentration 
gradient. It is important to note that diffusion will bring 
about 105 molecules into the vicinity of the channel 
entrance, but only 0.1% of these molecules are effectively 
translocated. Inspection of Equation 3 shows that the 
permeation is limited by the on rate only and is about 100 
times slower than an optimized solution as the maltose 
permeates through a single maltoporin channel.
Molecular modelling studies of β‑lactam translocation 
through OmpF. The recent availability of high-resolution 
porin structures combined with a new generation of 
powerful computers and new software has made it pos-
sible to model transport pathways for antibiotic mol-
ecules68,79. Molecular dynamic simulations allow a view 
of the dynamics of a number of processes at an atomic 
level by integrating newton’s equation of motion. The 
currently available computation time limits the system 
to about 100,000 molecules and a few nanoseconds. 
Clearly, permeation of antibiotics is far beyond this range. 
Metadynamics modelling is an adaptation that is designed 
to improve the sensitivity of these model systems. It 
can capture ‘rare’ events, such as an antibiotic molecule 
encountering and entering a porin channel, and is based 
Figure 3 | Antibiotic docking to porin channels. A model for ampicillin docking in the 
narrowest part of the OmpF monomeric pore (top view). The zwitterionic ampicillin 
molecule simultaneously interacts with the positively and negatively charged residues  
at the constriction zone that is formed by the β-barrel wall and internal loop 3. On one 
side, the carboxylate ampicillin group is attracted to the cluster of positively charged 
residues in the pore, and on the opposite side the ammonium ampicillin group is 
attracted to the carboxylate of Glu117. In the top panel, the skeleton of OmpF is shown in 
a ribbon representation in yellow. Key residues inside the pore are highlighted with stick 
representation. The antibiotic molecule is shown as a transparent Corey–Pauling–Koltun 
model. Green spheres are carbon atoms, red spheres are oxygen atoms, blue spheres are 
nitrogen atoms and the yellow sphere is a sulphur atom. For clarity, hydrogen atoms of 
ampicillin are not shown. In the bottom panel, the distribution of the electrostatic 
potential of the solvent-accessible molecular surface of the OmpF constriction zone 
complexed with ampicillin is represented with the GRASP program69. Red zones are 
negative potentials and blue zones are positive potentials. The ampicillin molecule is 
represented as a stick model. White sticks are carbon atoms, red sticks are oxygen atoms, 
blue sticks are nitrogen atoms, the green stick is a sulphur atom and violet sticks are 
hydrogen atoms69,70. Reproduced, with permission, from rEF 69  (2002) National 
Academy of Sciences.
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Metadynamics modelling
A method to simulate rare 
events on the basis of the 
choice of the relevant variables 
of a process and on the 
acceleration of these variables.
on an algorithm that limits backward motion. Ceccarelli 
and co-workers79 applied this new algorithm to elucidate 
possible pathways of ampicillin through the OmpF chan-
nel. In a recent publication the pathways of five different 
β-lactams (ampicillin, amoxicillin, piperacillin, azlocillin 
and carbenicillin) through OmpF were evaluated68. The 
model predicts that azlocillin and piperacillin are too 
bulky to permeate through the channel, whereas ampicil-
lin and amoxicillin permeate well and two affinity pock-
ets have been elucidated. In a second step, transition state 
theory accounts for the energy gain that is observed owing 
to the presence of an affinity pocket in the channel and 
relates this to the kinetics of permeation. The transition 
state theory provides Equation 4.
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k = (l/τ) exp(–∆G/kBT) (4)
In Equation 4, k is the corresponding rate constant 
and τ is the inverse pre-exponential. In the exponent, ∆G 
is the energy difference calculated from the molecular 
modelling and kbT is the boltzmann factor. Originally, 
this theory was derived for reactions in the gas phase, 
and the pre-exponential corresponds to the number of 
molecular trials needed to overcome the barrier (number 
of ‘hits’). In condensed phase, this value is replaced by a 
more complex relationship. another possible approach 
to model the pathway through the channel would be to 
apply a force to the antibiotic molecule and to drag it 
through the channel. For both methods, the pathway, 
possible electrostatic interactions and interaction with 
the channel can be obtained. However, the measured per-
meation values are obtained from modelling indirectly 
through an extrapolation into the experimentally avail-
able millisecond range, and thus any conclusions must be 
treated with caution.
To conclude, the chemical properties of antibiotic 
molecules influence their transport through their inter-
actions with the porin channels. For example, zwitteri-
onic compounds penetrate proteoliposomes and live 
cells rapidly and exhibit increased ion flux perturbations 
through OmpF in lipid bilayer models compared with 
other charged compounds32. large molecules, with bulky 
side chains, such as azlocillin and piperacillin have low 
permeation rates68. In addition, the translocation of rep-
resentatives of more recent β-lactams (carbapenems and 
cephalosporins) through Omp36 (an OmpC analogue) 
has been quantified (C. James, unpublished observations). 
Key exposed residues have been identified that transiently 
interact with translocating molecules to strongly influ-
ence the rate of permeation68,75. substitution mutations 
at such sites in OmpF and OmpC can alter the suscep-
tibility to certain β-lactams and can represent a bacterial 
drug-resistance strategy to restrict antibiotic influx.
Concluding remarks
This Review has summarized the clinical evidence for 
a progressive alteration of membrane permeability by 
Gram-negative bacteria. This leads to an MDR pheno-
type partly as a result of modified porin expression and 
reflects a rapid adaptive response to antibiotic stress. The 
control of bacterial membrane permeability is a complex 
process that is tightly regulated by an intricate network 
of systems that sense and respond to osmotic shock, pH, 
temperature, antibiotics and chemical stress33,80–82.
bacteria make use of sophisticated regulation cascades 
that detect different toxic compounds and respond by elic-
iting various resistance mechanisms. Documenting the 
emergence or acquisition of antibiotic resistance mecha-
nisms during antibiotherapy highlights the efficiency of 
the bacterial adaptive response. In this respect, decreased 
membrane permeability reduces the internal accumula-
tion of antibiotics, therefore allowing time for the devel-
opment of further resistance mechanisms, such as target 
modification or drug inactivation. This information is 
of importance for understanding the bacterial resistance 
that is triggered by the modification of membrane per-
meability and for the development of new antibiotherapy 
strategies.
Translocation across the porin channel is the first 
step in the journey of a β-lactam to its target site. 
Consequently, deciphering antibiotic translocation 
through porins at the molecular level is crucial for 
understanding the correlation between influx and anti-
biotic activities in bacteria. state of the art techniques 
have been developed to this end, using high-resolution 
ion current analysis together with structure and dynamic 
modelling. Together with mutational studies, these 
methods have identified specific amino-acid residues 
that are located inside the channel that play a key part 
in β-lactam diffusion efficiency to influence overall 
antibiotic activity. These data are crucial for elucidating 
the antibiotic pathway through the porin channel and 
provide molecular insights which could enable rational 
drug design to further optimize permeation and sup-
port new strategies to circumvent the ‘impermeability’ 
resistance mechanism.
1. Rice, L. B. Emerging issues in the management  
of infections caused by multidrug-resistant  
gram-negative bacteria. Cleve Clin. J. Med.  
74, S12–S20 (2007).
2. Blot, S., Depuydt, P., Vandewoude, K. &  
De Bacquer, D. Measuring the impact of multidrug 
resistance in nosocomial infection. Curr. Opin. Infect. 
Dis. 20, 391–396 (2007).
3. Sheridan, C. Antiinfective biotechs face partnering 
gap. Nature Biotechnol. 23, 155–156 (2005).
4.  Norrby, S. R., Nord, C. E. & Finch, R. Lack of 
development of new antimicrobial drugs: a potential 
serious threat to public health. Lancet Infect. Dis.  
5, 115–119 (2005).
5. Li, X. Z. & Nikaido, H. Efflux-mediated drug  
resistance in bacteria. Drugs 64, 159–204 (2004).
6. Davin-Regli, A. et al. Membrane permeability and 
regulation of drug “influx and efflux” in enterobacterial 
pathogens. Curr. Drug Targets 9, 750–759 (2008).
7. Piddock, L. J. Multidrug-resistance efflux  
pumps — not just for resistance. Nature Rev. 
Microbiol. 4, 629–636 (2006).
8. Poole, K. Efflux-mediated antimicrobial resistance. 
J. Antimicrob. Chemother. 56, 20–51 (2005).
9. Nikaido, H. Molecular basis of bacterial outer 
membrane permeability revisited. Microbiol. Mol. 
Biol. Rev. 67, 593–656 (2003).
10. Delcour, A. H. Solute uptake through general  
porins. Front. Biosci. 8, D1055–D1071 (2003).
11. Schulz, G. E. The structure of bacterial outer 
membrane proteins. Biochim. Biophys. Acta  
1565, 308–317 (2002).
12. Koebnik, R., Locher, K. P. & Van Gelder, P. Structure 
and function of bacterial outer membrane proteins: 
barrels in a nutshell. Mol. Microbiol. 37, 239–253 
(2000).
13. Guillier, M., Gottesman, S. & Storz, G. Modulating  
the outer membrane with small RNAs. Genes Dev.  
20, 2338–2348 (2006).
14. Pagès, J.-M. Role of bacterial porins in antibiotic 
susceptibility of Gram-negative bacteria in Bacterial 
and Eukaryotic Porins (ed. Benz, R.) 41–59 (Wiley-
VCH, Weinheim, 2004).
15. Davin-Régli, A. & Pagès, J.-M. in Antimicrobial 
Resistance in Bacteria (ed. Zmabiles-Cuevos, C. F.) 
55–75 (Horizon Biosciences, Norfolk, 2006)
16. Bryskier, A. (ed.) Antimicrobial Agents: Antibacterials 
and Antifungals (ASM Press, Washington, 2005). 
R E V I E W S
naTuRE REvIEws | microbiology  vOluME 6 | DECEMbER 2008 | 901
17. Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, 
C. A. & Collins, J. J. A common mechanism of cellular 
death induced by bactericidal antibiotics. Cell 130, 
797–810 (2007).
18. Nestorovich. E. M., Sugawara, E., Nikaido, H. &. 
Bezrukov, S. M. Pseudomonas aeruginosa porin  
OprF. Properties of the channel. J. Biol. Chem.  
281, 16230–16237 (2006).
19. Sugawara, E., Nestorovich. E. M., Bezrukov, S. M. & 
Nikaido, H. Pseudomonas aeruginosa porin OprF 
exists in two different conformations. J. Biol. Chem. 
281, 16220–16229 (2006).
20.  Hancock, R. E. & Brinkman, F. S. Function of 
Pseudomonas porins in uptake and efflux.  
Annu. Rev. Microbiol. 56, 17–38 (2002).
21. Nikaido, H. Outer membrane barrier as a 
mechanism of antimicrobial resistance. Antimicrob. 
Agents Chemother. 33, 1831–1836 (1989).
22. Hasdemir, U. O., Chevalier, J., Nordmann, P. &  
Pagès, J.-M. Detection and prevalence of active  
drug efflux mechanism in various multidrug-
resistant Klebsiella pneumoniae strains from 
Turkey. J. Clin. Microbiol. 42, 2701–2706  
(2004).
23. Doménech-Sánchez, A. et al. Role of Klebsiella 
pneumoniae OmpK35 porin in antimicrobial 
resistance. Antimicrob. Agents Chemother.  
47, 3332–3335 (2003).
24. Hernández-Allés, S. et al. Relationship between  
outer membrane alterations and susceptibility  
to antimicrobial agents in isogenic strains of  
Klebsiella pneumoniae. J. Antimicrob. Chemother.  
46, 273–277 (2000).
25. Martínez-Martínez, L. et al. Energy-dependent 
accumulation of norfloxacin and porin expression  
in clinical isolates of Klebsiella pneumoniae and 
relationship to extended-spectrum β-lactamase 
production. Antimicrob. Agents Chemother.  
46, 3926–3932 (2002).
26. Jacoby, G. A., Mills, D. M. & Chow, N. Role of 
β-lactamases and porins in resistance to ertapenem 
and other β-lactams in Klebsiella pneumoniae. 
Antimicrob. Agents Chemother. 48, 3203–3206 
(2004).
27. Kaczmarek, F. M., Dib-Hajj, F., Shang, W. & Gootz, T. D. 
High-level carbapenem resistance in a Klebsiella 
pneumoniae clinical isolate is due to the combination of 
bla(ACT-1) β-lactamase production, porin OmpK35/36 
insertional inactivation, and down-regulation of the 
phosphate transport porin phoe. Antimicrob. Agents 
Chemother. 50, 3396–3406 (2006).
28. Mena, A. et al. Characterization of a large outbreak  
by CTX-M-1-producing Klebsiella pneumoniae and 
mechanisms leading to in vivo carbapenem 
resistance development. J. Clin. Microbiol. 44, 
2831–2837 (2006).
29. Loli, A. et al. Sources of diversity of carbapenem 
resistance levels in Klebsiella pneumoniae carrying 
blaVIM-1. J. Antimicrob. Chemother. 58, 669–672 
(2006).
30. Elliott, E. et al. In vivo development of ertapenem 
resistance in a patient with pneumonia caused by 
Klebsiella pneumoniae with an extended-spectrum 
β-lactamase. Clin. Infect. Dis. 42, e95–e98 (2006).
31. Medeiros, A. A., O’Brien, T. F., Rosenberg, E. Y. & 
Nikaido, H. Loss of OmpC porin in a strain of 
Salmonella typhimurium causes increased resistance 
to cephalosporins during therapy. J. Infect. Dis.  
156, 751–757 (1987).
32. Yoshimura, F. & Nikaido, H. Diffusion of β-lactam 
antibiotics through the porin channels of Escherichia 
coli K-12. Antimicrob. Agents Chemother. 27, 84–92 
(1985).
The first complete study on the diffusion rate of 
β-lactam molecules through E. coli porins.
33. Ferenci, T. Maintaining a healthy SPANC balance 
through regulatory and mutational adaptation.  
Mol. Microbiol. 57, 1–8 (2005).
34. Prilipov, A., Phale, P. S., Koebnik, R., Widmer, C. & 
Rosenbusch, J. P. Identification and characterization  
of two quiescent porin genes, nmpC and ompN, in 
Escherichia coli BE. J. Bacteriol. 180, 3388–3392 
(1998).
35. Doménech-Sánchez, A., Hernández-Allés, S.,  
Martínez-Martínez, L., Benedí, V. J. & Albertí, S. 
Identification and characterization of a new porin  
gene of Klebsiella pneumoniae: its role in β-lactam 
antibiotic resistance. J. Bacteriol. 181, 2726–2732 
(1999).
36. Bornet, C., Davin-Régli, A., Bosi, C., Pagès, J.-M. & 
Bollet, C. Imipenem resistance of Enterobacter 
aerogenes mediated by outer membrane 
permeability. J. Clin. Microbiol. 38, 1048–1052 
(2000).
37. Bosi, C. et al. Most Enterobacter aerogenes strains  
in France belong to a prevalent clone. Clin. 
Microbiol. 37, 2165–2169 (1999).
38. Bornet, C. et al. Imipenem and expression of 
multidrug efflux pump in Enterobacter aerogenes. 
Biochem. Biophys. Res. Commun. 301, 985–990 
(2003).
39. Charrel, R. N., Pagès, J.-M., De Micco, P. & Malléa, 
M. Prevalence of outer membrane porin alteration in 
β-lactam-antibiotic-resistant Enterobacter 
aerogenes. Antimicrob. Agents Chemother. 40, 
2854–2858 (1996).
40. Thiolas, A., Bollet, C., La Scola, B., Raoult, D. &  
Pagès, J.-M. Successive emergence of Enterobacter 
aerogenes strains resistant to imipenem and  
colistin in a patient. Antimicrob. Agents Chemother. 
49, 1354–1358 (2005).
41. Szabó, D. et al. Outer membrane protein changes  
and efflux pump expression together may confer 
resistance to ertapenem in Enterobacter cloacae. 
Antimicrob. Agents Chemother. 50, 2833–2835 
(2006).
42. Randall, L. P. & Woodward, M. J. The multiple 
antibiotic resistance (mar) locus and its significance. 
Res. Vet. Sci. 72, 87–93 (2002).
43. Hernández-Allés, S. et al. Development of resistance 
during antimicrobial therapy caused by insertion 
sequence interruption of porin genes. Antimicrob. 
Agents Chemother. 43, 937–939 (1999).
44. Mena, A. et al. Characterization of a large outbreak  
by CTX-M-1-producing Klebsiella pneumoniae and 
mechanisms leading to in vivo carbapenem 
resistance development. J. Clin. Microbiol. 44, 
2831–2837 (2006).
45. Cai, J. C., Zhou, H. W., Zhang, R. & Chen, G. X. 
Emergence of Serratia marcescens, Klebsiella 
pneumoniae, and Escherichia coli isolates 
possessing the plasmid-mediated carbapenem-
hydrolyzing β-lactamase KPC-2 in intensive care 
units of a  
Chinese hospital. Antimicrob. Agents Chemother.  
52, 2014–2018 (2008).
46. Simonet, V., Malléa, M., Fourel, D., Bolla, J. M. & 
Pagès, J.-M. Crucial domains are conserved in 
Enterobacteriaceae porins. FEMS Microbiol.  
Lett. 136, 91–97 (1996).
47. Low, A. S., MacKenzie, F. M., Gould, I. M. &  
Booth, I. R. Protected environments allow parallel 
evolution of a bacterial pathogen in a patient 
subjected to long-term antibiotic therapy.  
Mol. Microbiol. 42, 619–630 (2001).
48. Malléa, M. et al. Porin alteration and active  
efflux: two in vivo drug resistance strategies  
used by Enterobacter aerogenes. Microbiology  
144, 3003–3009 (1998).
49. Dé, E. et al. A new mechanism of antibiotic  
resistance in Enterobacteriaceae induced by  
a structural modification of the major porin.  
Mol. Microbiol. 41, 189–198 (2001).
The first description of a clinical isolate with a 
mutation in internal loop 3.
50. Jeanteur, D. et al. Structural and functional 
alterations of a colicin-resistant mutant of OmpF 
porin from Escherichia coli. Proc. Natl Acad. Sci. 
USA 91, 10675–10679 (1994).
51. Simonet, V., Malléa, M. & Pagès, J.-M. Substitutions 
in the eyelet region disrupt cefepime diffusion 
through the Escherichia coli OmpF channel. 
Antimicrob. Agents Chemother. 44, 311–315 
(2000).
52. Thiolas, A., Bornet, C., Davin-Régli, A., Pagès, 
J.-M. & Bollet, C. Resistance to imipenem, 
cefepime, and cefpirome associated with mutation 
in Omp36 osmoporin of Enterobacter aerogenes. 
Biochem. Biophys. Res. Commun. 317, 851–856 
(2004).
53. Chevalier, J., Pagès, J.-M. & Malléa, M. In vivo 
modification of porin activity conferring antibiotic 
resistance to Enterobacter aerogenes. Biochem. 
Biophys. Res. Commun. 266, 248–251 (1999).
54. Olesky, M., Hobbs, M. & Nicholas, R. A. 
Identification and analysis of amino acid mutations 
in porin IB that mediate intermediate-level 
resistance to penicillin and tetracycline in Neisseria 
gonorrhoeae. Antimicrob. Agents Chemother. 46, 
2811–2820 (2002).
55. Olesky, M., Zhao, S., Rosenberg, R. L. & Nicholas, R. A. 
Porin-mediated antibiotic resistance in Neisseria 
gonorrhoeae: ion, solute, and antibiotic permeation 
through PIB proteins with penB mutations. 
J. Bacteriol. 188, 2300–2308 (2006).
56. Veal, W. L., Nicholas, R. A. & Shafer, W. M. 
Overexpression of the MtrC–MtrD–MtrE efflux 
pump due to an MtrR mutation is required for 
chromosomally mediated penicillin resistance in 
Neisseria gonorrhoeae. J. Bacteriol. 184,  
5619–5624 (2002).
57. Shafer, W. M. & Folster, J. P. Towards an understanding 
of chromosomally mediated penicillin resistance in 
Neisseria gonorrhoeae: evidence for a porin-efflux 
pump collaboration. J. Bacteriol. 188, 2297–2299 
(2006).
58. Ochs, M. M., Bains, M. & Hancock, R. E. Role of 
putative loops 2 and 3 in imipenem passage through 
the specific porin OprD of Pseudomonas aeruginosa. 
Antimicrob. Agents Chemother. 44, 1983–1985 
(2000).
59. Wolter, D. J., Hanson, N. D. & Lister, P. D. Insertional 
inactivation of oprD in clinical isolates of 
Pseudomonas aeruginosa leading to carbapenem 
resistance. FEMS Microbiol. Lett. 236, 137–143 
(2004).
60. Epp, S. F. et al. C-terminal region of Pseudomonas 
aeruginosa outer membrane porin OprD modulates 
susceptibility to meropenem. Antimicrob. Agents 
Chemother. 45, 1780–1787 (2001).
61. Biswas, S., Mohammad, M. M., Patel, D. R., 
Movileanu, L. & van den Berg, B. Structural insight into 
OprD substrate specificity. Nature Struct. Mol. Biol. 
14, 1108–1109 (2007).
62. El Amin, N. et al. Carbapenem resistance mechanisms 
in Pseudomonas aeruginosa: alterations of porin OprD 
and efflux proteins do not fully explain resistance 
patterns observed in clinical isolates. APMIS 113, 
187–196 (2005).
63. Luckey, M. & Nikaido, H. Specificity of diffusion 
channels produced by λ phage receptor protein of 
Escherichia coli. Proc. Natl Acad. Sci. USA 77,  
167–171 (1980).
64. Nikaido, H. & Rosenberg, E. Y. Porin channels in 
Escherichia coli: studies with liposomes reconstituted 
from purified proteins. J. Bacteriol. 153, 241–252 
(1983).
65. Rodrigues, C., Gameiro, P., Prieto, M. & de Castro, B. 
Interaction of rifampicin and isoniazid with large 
unilamellar liposomes: spectroscopic location 
studies. Biochimica Biophysica Acta 1620, 151–159 
(2003).
66. Cowan, S. W. et al. Crystal structures explain functional 
properties of two E. coli porins. Nature 358, 727–733 
(1992).
The three-dimensional structures of OmpF and 
PhoE explained the channel properties of E. coli 
porins.
67. Baslé, A., Rummel, G., Storici, P., Rosenbusch, J. P. & 
Schirmer, T. Crystal structure of osmoporin OmpC from 
E. coli at 2A. J. Mol. Biol. 362, 933–942 (2006).
Reported the three-dimensional structure of E. coli 
OmpC porin.
68. Danelon, C., Nestrovich, E. M., Winterhalter, M., 
Ceccarelli, M. & Bezrukov, S. M. Interaction of 
zwitterionic penicillins with the OmpF channel 
facilitates their translocation. Biophys. J. 90,  
1617–1627 (2006).
69. Nestorovich, E. M., Danelon, C., Winterhalter, M. & 
Bezrukov, S. M. Designed to penetrate: time-resolved 
interaction of single antibiotic molecules with bacterial 
pores. Proc. Natl Acad. Sci. USA 99, 9789–9794 
(2002).
The first characterization of the β-lactam 
permeation through OmpF on a single molecular 
level.
70. Danelon, C., Brando, T. & Winterhalter, M.  
Probing the orientation of reconstituted maltoporin 
channels at the single-protein level. J. Biol. Chem. 278, 
35542–35551 (2003).
71. Kullman L, Winterhalter M. & Bezrukov S. M. 
Transport of maltodextrins through maltoporin. A 
single-channel study. Biophys. J. 82, 803–812 (2002).
72. Bezrukov, S. M. & Winterhalter, M. Examining  
noise sources at the single-molecule level: 1/f noise  
of an open maltoporin channel. Phys. Rev. Lett.  
85, 202–205 (2000).
73. Nekolla, S., Andersen, C. & Benz, R. Noise analysis  
of ion current through the open and the sugar-induced 
closed state of the LamB channel of Escherichia coli 
outer membrane: evaluation of the sugar binding 
kinetics to the channel interior Biophys. J. 66,  
1388–1397 (1994).
R E V I E W S
902 | DECEMbER 2008 | vOluME 6  www.nature.com/reviews/micro
74. Schwarz, G., Danelon, C. & Winterhalter, M. On 
translocation through a membrane channel via an 
internal binding site: kinetics and voltage dependence. 
Biophy. J. 84, 2990–2998 (2003).
75. Vidal, S., Bredin, J., Pagès, J.-M. & Barbe, J. 
β-lactam screening by specific residues of the OmpF 
eyelet. J. Med. Chem. 48, 1395–1400 (2005).
76. Berezhkovskii, A. M. & Bezrukov, S. M. Optimizing 
transport of metabolites through large channels: 
molecular sieves with and without binding.  
Biophys. J. 88, L17–L19 (2005).
77. Bauer, W. R. & Nadler, W. Molecular transport 
through channels and pores: effects of in-channel 
interactions and blocking. Proc. Natl Acad. Sci. USA 
103, 11446–11451 (2006).
78. Bezrukov, S. M., Berezhkovskii, A. M. & Szabo, A. 
Diffusion model of solute dynamics in a membrane 
channel: mapping onto the two-site model and 
optimizing the flux. J. Chem. Phys. 127, 115101 
(2007).
79. Ceccarelli, M., Danelon, C., Laio, A. & Parrinello, M. 
Microscopic mechanism of antibiotics translocation 
through a porin. Biophys. J. 87, 58–64 (2004).
80. Giuliodori, A. M., Gualerzi, C. O., Soto, S., Vila, J. & 
Tavío, M. M. Review on bacterial stress topics.  
Ann. NY Acad. Sci. 1113, 95–104 (2007).
81. Valentin-Hansen, P., Johansen, J. & Rasmussen, A. A. 
Small RNAs controlling outer membrane porins. Curr. 
Opin. Microbiol. 10, 152–155 (2007).
82. Viveiros, M. et al. Antibiotic stress, genetic response 
and altered permeability of E. coli. PLoS ONE 2, 
e365 (2007).
83. Baslé, A. & Delcour, A. H. Effect of two polyamine 
toxins on the bacterial porin OmpF. Biochem. 
Biophys. Res. Commun. 285, 550–554  
(2001).
84. Iyer, R., Wu, Z., Woster, P. M. & Delcour, A. H. 
Molecular basis for the polyamine-ompF porin 
interactions: inhibitor and mutant studies.  
J. Mol. Biol. 297, 933–945 (2000).
85. Iyer, R. & Delcour, A. H. Complex inhibition  
of OmpF and OmpC bacterial porins by polyamines. 
J. Biol. Chem. 272, 18595–18601 (1997).
86. Vidal, S. et al. Computer simulation of spermine–
porin channel interactions. In Vivo 16, 111–116 
(2002).
87. Bredin, J., Simonet, V., Iyer, R., Delcour, A. H. & 
Pagès, J.-M. Colicins, spermine and cephalosporins:  
a competitive interaction with the OmpF eyelet. 
Biochem. J. 376, 245–252 (2003).
88. Chevalier, J., Malléa, M. & Pagès, J.-M. 
Comparative aspects of the diffusion of norfloxacin, 
cefepime and spermine through the F porin 
channel of Enterobacter cloacae. Biochem. J. 348, 
223–227 (2000).
89. Samartzidou, H. & Delcour, A. H. Excretion of 
endogenous cadaverine leads to a decrease in  
porin-mediated outer membrane permeability. 
J. Bacteriol. 181, 791–798 (1999).
90. Samartzidou, H., Mehrazin, M., Xu, Z., Benedik, 
M. J. & Delcour, A. H. Cadaverine inhibition of porin 
plays a role in cell survival at acidic pH. J. Bacteriol. 
185, 13–19 (2003).
91. Bower, J. M. & Mulvey, M. A. Polyamine-mediated 
resistance of uropathogenic Escherichia coli to 
nitrosative stress. J. Bacteriol. 188, 928–933 (2006).
92. Dutzler, R. et al. Crystal structure and functional 
characterization of OmpK36, the osmoporin of 
Klebsiella pneumoniae. Structure 7, 425–434 
(1999).
93. Mach, T., Chimerel, C., Fritz, J., Fertig, N., 
Winterhalter, M. &. Fütterer, C. Miniaturized planar 
lipid bilayer: increased stability, low electric noise 
and fast fluid perfusion. Analytical Bionanalyt. 
Chem. 390, 341–346 (2008).
Acknowledgements
Support for this project was obtained through European Union 
grant MRTN-CT-2005–019335 “Translocation”, COST Action 
BM0701 “ATENS” and from the Université de la Méditerranée 
and Service de Santé des Armées.
DATABASES
Entrez Genome Project: 
http://www.ncbi.nlm.nih.gov/sites/entrez?db=genomeprj
Acinetobacter baumannii | Enterobacter cloacae | Escherichia 
coli | Klebsiella pneumoniae | Neisseria gonorrhoeae | 
Pseudomonas aeruginosa | S. typhi
UniProtKB: http://ca.expasy.org/sprot
OmpC | OmpF | OmpK35 | OmpK36 | OmpK37 | PhoE 
FURTHER INFORMATION
Jean-Marie Pagès’ homepage: http://www.univmed.fr/
recherche/unites.aspx?id=172&prt=5
Mathias Winterhalter’s homepage: http://www.faculty.
iu-bremen.de/mwinterhalter/
Transport Protein Database:  
http://www.biology.ucsd.edu/~msaier/transport
All links Are Active in the online PDf
R E V I E W S
naTuRE REvIEws | microbiology  vOluME 6 | DECEMbER 2008 | 903
